HomeHealthcare and Life Sciences Europe 3D Printed Drugs Market

Europe 3D Printed Drugs Market Size, Share, Growth, and Industry Analysis, By Technology (Inkjet Printing, Fused Deposition Modeling, Stereolithography), By Application (Neurology, Oncology, Orthopedics), Regional Insights and Forecast to 2034

Report Code: SMI210PUB
Last Updated : April, 2026
Author : Jessica Richardson

Table of Contents

  1. Executive Summary
    1. Introduction
  2. Market Introduction
    1. Market Definition
    2. Scope of the Study
    3. Market Structure
  3. Research Methodology
    1. Primary Research
    2. Research Methodology
    3. Assumptions & Exclusions
    4. Secondary Data Sources
  4. Market Factor Analysis
    1. Value Chain Analysis: Europe 3D Printed Drugs Market
    2. Porters Five Forces Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitution
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Dynamics
    1. Drivers
    2. Restraints
    3. Opportunities
  6. Recent Trends Analysis
  7. Impact of COVID-19 on Europe 3D Printed Drugs Market
    1. Pre and Post Covid -19 Market Scenario Analysis
    2. Market Recovery Timeline and Challenge
    3. Measures Taken by Top Players
  8. Regulatory Landscape
  9. Europe 3D Printed Drugs Market, Technology
    1. Introduction
      1. Market Size and Forecast, Technology
    2. Inkjet Printing
      1. Market Size and Forecast, By Region
    3. Fused Deposition Modeling
      1. Market Size and Forecast, By Region
    4. Stereolithography
      1. Market Size and Forecast, By Region
  10. Europe 3D Printed Drugs Market, Application
    1. Introduction
      1. Market Size and Forecast, Application
    2. Neurology
      1. Market Size and Forecast, By Region
    3. Oncology
      1. Market Size and Forecast, By Region
    4. Orthopedics
      1. Market Size and Forecast, By Region
  11. Regional Overview
    1. Introduction
      1. Market Size and Forecast
    2. Europe
      1. Market Size and Forecast
        1. Technology
          1. Inkjet Printing
            1. Fused Deposition Modeling
              1. Stereolithography
              2. Application
                1. Neurology
                  1. Oncology
                    1. Orthopedics
                  2. U.K.
                    1. Technology
                      1. Inkjet Printing
                        1. Fused Deposition Modeling
                          1. Stereolithography
                          2. Application
                            1. Neurology
                              1. Oncology
                                1. Orthopedics
                              2. Germany
                              3. France
                              4. Spain
                              5. Italy
                              6. Russia
                              7. Nordic
                              8. Benelux
                              9. Rest of Europe
                          3. Competitive Landscape, 2025
                            1. Introduction
                            2. Europe 3D Printed Drugs Market Share Analysis, 2025 (%)
                              1. Market Share Analysis, 2025
                              2. Competition Ranking, 2025
                              3. Key Developments & Growth Strategies
                                1. Merger & Acquisition
                                2. Product Launch
                                3. Expansion
                              4. Consolidated SWOT Analysis of Key Players
                          4. Company Profile
                            1. Aprecia Pharmaceuticals
                              1. Business Overview
                              2. Financial Data
                              3. Key Product domains
                              4. Recent Developments
                            2. FabRx Ltd
                            3. Merck Group
                            4. GlaxoSmithKline plc
                            5. Johnson & Johnson
                            6. Pfizer Inc.
                            7. Sanofi S.A.
                            8. Bayer AG
                            9. Novartis AG
                            10. AstraZeneca plc
                            11. Roche Holding AG
                            12. Teva Pharmaceutical Industries

                          Request Free Sample